HLA as a risk factor for neuroleptic induced tardive dyskinesia in schizophrenia
β Scribed by Wright, P.; Donaldson, P.T.; Underhill, J.A.; Murray, R.M.
- Book ID
- 123464893
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 86 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0920-9964
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We examined whether an oral challenge dose of the amino acid phenylalanine (a dopamine precursor) exacerbates the abnormal movements of tardive dyskinesia (TD). We also examined age, gender, treatment duration, and baseline movement severity in relation to phenylalanine-induced changes in movements.
## Abstract A metaβanalysis of prospective studies with schizophrenia patients was conducted to examine whether the evidence exists for risk factors for the emergence of Tardive Dyskinesia (TD) in schizophrenia. A computer assisted Medline/PubMed and Embase search was conducted in January 2008 for